SKYE - Skye Bioscience, Common Stock - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

SKYE is currently covered by 2 analysts with an average price target of $13.23. This is a potential upside of $9.22 (229.93%) from yesterday's end of day stock price of $4.01.

Skye Bioscience, Common Stock's activity chart (see below) currently has 0 price targets and 8 ratings on display. The stock rating distribution of SKYE is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 50% with an average time for these price targets to be met of 11 days.

Highest price target for SKYE is $14, Lowest price target is $14, average price target is $14.

Most recent stock forecast was given by KRISTEN KLUSKA from CANTOR FITZGERALD on 20-Sep-2024. First documented stock forecast 05-Feb-2024.

Best performing analysts who are covering SKYE - Skye Bioscience, Common Stock:

Kristen Kluska Edward Tenthoff

Currently out of the existing stock ratings of SKYE, 8 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$14

$10.11 (259.90%)

$14

10 months 4 days ago
(20-Sep-2024)

0/6 (0%)

$10.86 (345.86%)

Buy

$12

10 months 4 days ago
(20-Sep-2024)

1/1 (100%)

$7.57 (170.88%)

22

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is SKYE (Skye Bioscience, Common Stock) average time for price targets to be met?

On average it took 11 days on average for the stock forecasts to be realized with a an average price target met ratio 50

Which analyst has the current highest performing score on SKYE (Skye Bioscience, Common Stock) with a proven track record?

KRISTEN KLUSKA

Which analyst has the current lower performing score on SKYE (Skye Bioscience, Common Stock) with a proven track record?

EDWARD TENTHOFF

Which analyst has the most public recommendations on SKYE (Skye Bioscience, Common Stock)?

Kristen Kluska works at CANTOR FITZGERALD and has 2 price targets and 3 ratings on SKYE

Which analyst is the currently most bullish on SKYE (Skye Bioscience, Common Stock)?

Kristen Kluska with highest potential upside - $10.11

Which analyst is the currently most reserved on SKYE (Skye Bioscience, Common Stock)?

Edward Tenthoff with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?